STOK
Stoke Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.40 / 10
Netural
Analyst consensus is overwhelmingly bullish: 66.7% Strong Buy and 33.3% Buy across three research evaluations, with a historical weighted rating of 3.10. This aligns with a positive sentiment score of 5.4 and a fund-flow score of 7.7/10, indicating robust money inflows. However, fund-flow patterns reveal a nuanced picture—small-cap trends show positive inflow (0.50), while block, medium, large, and extra-large flows lean negative, suggesting potential short-term volatility despite the overall positive sentiment.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-05
InstitutionChardan Capital
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for STOK?
- STOK holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.40/10 (Netural).
